Sucrose dilaurate
| Product Name | Sucrose dilaurate |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-51135 |
| CAS No. | 25915-57-5 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 164.16 g/mol |
| Mol. For. | C6H12O5 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
SSEA-4 d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | i(Galb1,4GlcNAcb1,3Galb1,4GlcNAcb1,3GalbR) | iGB3Cer d18:1/18:0-Biotin (Gala1,3Galb1,4GlcbCeramide-Biotin) | Ac4 ManNAc | Neu5Aca2,3（HSO4 -6-)Galb1,4GlcNAc | FucGM1Cer d18:1/12:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Fucose 1-phosphate | GalNAcb1, 3Gal | Ac3 GlcNAcproN3 | GD3Cer d18:1/16:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GlcCer d18:1/20:0 (GlcbCeramide) | Lacto-N-difucohexaose | GT3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD1aCer d20:1/18:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT1c | GT2 | Galc d18:1/16:1（GalaCeramide） | GM2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcCer d20:1/18:0 (GlcbCeramide) | GlcCer d20:1/12:0 (GlcbCeramide) | GlcNAcb1, 3Gal | GT3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | GD1aCer d20:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d20:1/8:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM2 | GD1aCer d20:1/16:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1Cer d18:1/16:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bCer d18:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1aCer d18:1/18:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | B-Antigen-Cer d18:1/18:0-Biotin (Gala1,3(Fuca1,2)Galb1,4GlcbCeramide-Biotin) | GD3Cer d20:1/8:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD2Cer d18:1/18:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Ac3 6AzGlcNAc | GM1aCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1aCer d18:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d18:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Glucolepidiin potassium salt | GD3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | Sakuranin | GT2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d20:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3sph d18:1 (Neu5Aca2,3Galb1,4GlcbSphingolipids) | GD2sph d18:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | L-Xylonic acid | GM3Cer d20:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GM1bsph d18:1 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbSphingolipids) | GlcNAcb1, 3Galb1, 4(Fuca1, 3)GlcNAc | GlcNAcb1, 3Galb1, 4GlcNAc | GD2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bsph d18:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GD3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GQ3Cer d18:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | LewisaCer d20:1/24:1-Biotin (Galb1,3(Fuca1,4)GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | FucGM1Cer d18:1/24:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3sph d20:1 (Neu5Aca2,3Galb1,4GlcbSphingolipids) | GM3Cer d18:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | Gala1, 4Galb1, 4Glc | GlcCer d20:1/16:0 (GlcbCeramide) | Zymosan | GD2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Trifucosyllacto-N-hexaose | GQ3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Gb5 | GD1aCer d18:1/16:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d18:1/18:0-Biotin (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | nLc4 | Ac3 6AzGalNAc |